Inflammatory molecules and matrix metalloproteinase (MMPs) have been found over-expressed in the tear film of patients with keratoconus. However, the mechanistic link between inflammatory molecules and MMPs in the pathogenesis of keratoconus remains still elusive. Therefore, we investigated the effect of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) on MMP-1 expression and used IL-6 antibody (IL-6 Ab) to examine the role of IL-6 on TNF-a mediated regulation of MMP-1 in fibroblasts of normal cornea and keratoconus. Real-time polymerase chain reaction, Enzyme-linked immunosorbent assay, and Western blot data demonstrated that MMP-1 and IL-6 were expressed in fibroblasts of normal cornea and keratoconus. Levels of MMP-1 and IL-6 were significantly higher in keratoconus than normal cornea. TNF-a treatment led to a significant increase in IL-6 levels. IL-6 treatment induced MMP-1 synthesis in normal cornea and keratoconus. TNF-a increased MMP-1 expression in a dose-and time-dependent manner and this response was completely inhibited by the IL-6 Ab. In conclusion, these results indicate that fibroblasts of keratoconus shows increased levels of IL-6 and MMP-1 gene and protein expression and IL-6 mediates the TNF-a-induced MMP-1 expression.
Introduction
Keratoconus is defined as a non-inflammatory disease of the cornea, however, in recent years, several groups have demonstrated that the tear film in keratoconus showed increased levels of inflammatory molecules (IL-4, -5, -6, -8, TNF-a, -b) compared with normal controls. The extent of the increase was found to be associated with the severity of keratoconus. This suggested that the pathogenesis of keratoconus may involve chronic inflammatory events. [1] [2] [3] [4] Interleukin-6 (IL-6) is a pleiotropic cytokine with a wide range of biological activities in immune regulation, hematopoiesis, inflammation, and oncogenesis. 5, 6 IL-6 could play an important role in the generation of inflammation within the cornea. 7, 8 They are secreted mainly by lymphocytes and macrophages, but other cell types including corneal epithelial cells and corneal fibroblasts also secret them. 9, 10 Tumor necrosis factor-a (TNF-a) is widely considered an important cytokine mediator of inflammation and immune regulation that can cause a range of local and systemic biological effects in various cell types. 11, 12 TNF-a was also one of the cytokines capable of inducing IL-6 expression in human corneal epithelial cells. 13, 14 Furthermore, recent studies have demonstrated that TNF-a plays an important role in a variety of corneal diseases. [15] [16] [17] Matrix metalloproteinases (MMPs) are a family of zincdependent enzymes that are responsible for the degradation of extracellular matrix (ECM) and connective tissue protein. 18 In the human cornea, MMPs can be secreted by epithelial cells, stromal cells, and neutrophils. 19 Among MMPs, MMP-1, -2, -3, -7, -9, and -13 have been found to be elevated in the tear film of patients with keratoconus, indicating that MMPs may be involved in the pathogenesis of keratoconus. [20] [21] [22] [23] These findings suggest that the development of keratoconus may involve chronic inflammatory reaction and matrix degradation and there may be a potential link between inflammatory molecules and MMPs. Inflammatory cytokines such as IL-6 and TNF-a can modulate the expression of MMPs by human corneal epithelial cells. 24, 25 MMP-1 is mainly used for the degradation of collagen type I and III which are the major components of corneal ECM. 26 Therefore, in our study, we treated cultured fibroblasts of normal cornea and keratoconus with TNF-a, IL-6, and IL-6 antibody (IL-6 Ab) in vitro. We examined the MMP-1 levels in order to investigate the potential link between inflammatory molecules and MMPs during keratoconus.
Materials and methods
Isolation and culture of fibroblasts Keratoconus corneas (n ¼ 3. age / age range ¼ 18 or [16] [17] [18] [19] [20] were collected from patients with keratoconus who were undergoing corneal transplantation within 6-12 h following surgery from Shanxi Eye Hospital (Tai yuan, China). Normal corneas (n ¼ 3; age unknown) were obtained from discarded corneal remnants after corneal transplantation. The study was undertaken with the approval of the local ethics committee and after obtaining written informed consent from each patient. The epithelium and endothelium of corneas were mechanically removed. The corneal stroma was cut into several pieces with diameter of 1.0 mm. Subsequently, the small tissue pieces were digested into single cells with DMEM/F12 medium containing 2 mg/mL of type II collagenase. Cells were cultured in DMEM/F12 containing fetal bovine serum and in an air-5% CO 2 incubator at 37 C. Experiments were performed by using cells from passages 3-5.
For each experiment, fibroblasts were seeded at six-well plates with an initial density of 5 Â 10 5 /well. Cells were then treated with one of the following protocols: (1) TNF-a (1, 10, or 50 ng/mL; R&D Systems, Minneapolis, MN) for 12 h or with various stimulation time courses (2, 6, or 12 h) to test for MMP-1 and IL-6 expression; (2) IL-6 (6.25, 12.5, 25 or 50 ng/mL; R&D Systems) for 12 h or with various incubation times (2, 6, or 12 h) to test for MMP-1 expression; (3) 1 ng/mL TNF-a, or 25 ng/mL IL-6 or 1 ng/mL TNF-a þ 25 ng/mL IL-6 for 12 h to detect for MMP-1 expression; (4) 1 ng/mL TNF-a or 1 ng/mL TNF-a þ 40 ng/mL IL-6 Ab (Peprotech, Rocky Hill, NJ) for 12 h to test the production of IL-6 and MMP-1 expression. No significant cytotoxic effect on cell proliferation (data not shown). At the end of each experiment, the cells and supernatants from cell cultures were collected for gene or protein detection, respectively.
Real-time polymerase chain reaction (real-time PCR)
RNA extraction was performed according to the protocol reported previously. One microgram of RNA was converted to cDNA with the PrimeScript TM RT reagent Kit (TaKaRa Biotechnology CO., Dalian, China) by gradient PCR device (Eppendorf, Germany). Two microliters of 30-fold diluted cDNA products were amplified with SYBR Õ Premix Ex Taq TM II (TaKaRa Biotechnology CO) by the StepOnePlus TM Real-Time PCR System (Applied Biosystems, USA) using the following gene specific primers designed by Shanghai Sangon Biotechnology Co., Ltd. (Shanghai, China).
For quantification, IL-6 and MMP-1 mRNA expression were normalized to the expressed housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Realtime PCR conditions were as follows: 95 C for 30 s and then 40 cycles at 95 C for 5 s, 60 C for 30 s, and 72 C for 1 min, followed by 72 C for 10 min. The relative quantity of mRNA was calculated using the 2 ÀÁÁCt method.
Enzyme-linked immunosorbent assay (ELISA)
A human IL-6 ELISA kit (BioSource International, Camarillo, CA) was used to measure the IL-6 production in samples (10 mL cell-culture supernatant containing equal amounts of protein [15 mg]) according to the manufacturer's recommendations. The optical density was measured at 450 nm in a microplate reader (Multiskan Go, Thermo Scientific, USA).
Western blot
Equal amounts of protein (25 mg), as determined by the bicinchoninic acid (BCA) protein assay kit (Shanghai Sangon Biotechnology Co.), were loaded into a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Protein samples were mixed with loading buffer (20% glycerol, 10% 2-mercaptoethanol, 4% SDS, and 0.2 mg/mL bromophenol blue in 0.1 mol/L Tris-HCl [pH 6.8]), boiled and then separated by SDS-PAGE. Proteins were transferred to polyvinylidene difluoride (PVDF) membrane (Millipore, Billerica, MA). After blocking and washing, membranes were incubated overnight at 4 C with the primary antibody (Anti-MMP1 antibody, EP1247Y, ab52631, Abcam, Cambridge, MA) as indicated (1:2000 dilution) and then followed by incubation with a 1:7500 dilution of Goat Anti-Mouse IgG (Abcam) at room temperature. The membranes with protein bands were visualized by enhanced chemiluminescence detection reagents (Applygen Technologies Inc., Beijing, China) and exposed to X-ray film. Finally, densitometry of bands is measured by Image-Pro Plus 5.1.
Statistical analysis
All results were reported as mean AE standard deviation of three independent experiments and statistically performed by using SPSS v. 19 .0 software and one-way analysis of variance (ANOVA) analysis. Specific percentage changes have been provided in the online supplementary Tables 1-8. A P value < 0.05 was considered to indicate a statistically significant difference. 
Results

TNF-a induces MMP-1 mRNA expression and protein synthesis
Levels of MMP-1 mRNA in fibroblasts of keratoconus cultured without TNF-a were significantly higher than that in normal cornea and TNF-a up-regulated MMP-1 mRNA in a dose-dependent manner (P < 0.05) (Figure 1a ). MMP-1 protein levels in keratoconus without TNF-a were significantly higher than that in normal cornea and the levels in cells with TNF-a for 12 h began to increase at 1 ng/mL TNF-a, remained increased with concentration of 10 ng/mL TNF-a, and then decreased at 50 ng/mL TNF-a (P < 0.05) (Figure 1b and c). Levels of MMP-1 mRNA in fibroblasts of keratoconus without TNF-a were higher than that in normal cornea at 2, 6 or 12 h; Higher levels of MMP-1 mRNA in cultured cells under 1 ng/mL TNF-a for various stimulation times than that without TNF-a incubation (Figure 1d ); TNF-a up-regulated MMP-1 protein synthesis levels in cells incubated with 1 ng/mL TNF-a than that without TNF-a incubation and the levels increased in a time-dependent manner (P < 0.05) (Figure 1e-g) .
TNF-a up-regulates the levels of IL-6
Either IL-6 mRNA or protein levels in fibroblasts of keratoconus cultured without TNF-a for 12 h were significantly higher than that in normal cornea; TNF-a induced IL-6 mRNA and protein levels in a dose-dependent manner in cultured fibroblasts (P < 0.05) (Figure 2a and b) . Levels of IL-6 mRNA and protein in fibroblasts of keratoconus without TNF-a were higher than that in normal cornea at 2, 6 or 12 h; IL-6 mRNA expression in the presence of TNF-a (1 ng/mL) was increased than that in the absence of TNF-a at any indicated times intervals; moreover, incubation with 1 ng/mL TNF-a for 2 h increased the IL-6 protein levels than that without TNF-a, and greater up-regulation in IL-6 protein levels were found on stimulation with 1 ng/mL TNF-a for 6 h and 12 h (Figure 2c and d) .
IL-6 induces MMP-1 expression
IL-6 stimulation of fibroblasts induced a significant increase in MMP-1 mRNA and protein expression, at concentrations as low as 6.25 ng/mL for 12 h and with further increases upon stimulation with 12.5, 25, or 50 ng/mL for 12 h (P < 0.05, Figure 3a -c). Levels of MMP-1 mRNA were increased in cultured fibroblasts without IL-6 at 2 h and then reduced at 6 h, but later on, the levels were up-regulated at 12 h; IL-6 (25 ng/mL) up-regulated the levels of MMP-1 mRNA in cultured cells compared to their own control and the levels increased in a time-dependent manner (Figure 3d ). Moreover, incubation with 25 ng/mL 25 ng/mL IL-6 for 12 h were significantly higher (P < 0.05) than that in the cells cultured with 1 ng/mL TNF-a or 25 ng/mL IL-6 alone. The synergistic effect in fibroblasts of keratoconus was more obvious than normal cornea. IL-6 Ab treatment significantly inhibits TNF-a-induced the expression of MMP-1. The production of IL-6 protein in cell-culture supernatants from cells incubated with the addition of IL-6 Ab (40 ng/mL) was significantly combined (P < 0.05) (Figure 5a ). IL-6 Ab almost completely inhibited (P < 0.05) the TNF-a-mediated increases of MMP-1 mRNA expression ( Figure 5b ) and protein synthesis (Figure 5c and d) in cultured cells. The inhibitory effect on MMP-1 protein by IL-6 Ab in fibroblasts of keratoconus was more significant compared with normal cornea (Figure 5c and d) .
Discussion
In the present study, we have found that human corneal fibroblasts cultured in vitro could express IL-6 and MMP-1. Moreover, the expression of IL-6 and MMP-1 was significantly higher in cultured fibroblasts of keratoconus compared to normal cornea. This is consistent with the results of previous studies in the tear film of patients with keratoconus. 2, 3, 22 The MMP-1 overexpression might weaken the stability of structure of the cornea, by reason of its ability to degrade collagen type I and III, which are the main components of ECM in the cornea. 20, 26 Additionally, the synthesis of larger amounts of IL-6 by epithelial cells could influence a number of immunity and inflammation activities which could lead to corneal damage within the eye. 7 Since keratoconus is characterized by the thinning of the corneal stroma, taken together, these results of higher expressions on IL-6 and MMP-1 provide further support for that the pathogenesis of keratoconus may involve chronic inflammatory events and matrix degradation.
Previous reports have shown that MMPs levels are associated with increased concentration of inflammatory cytokines in a wide variety of cells. 24, 25 However, to date, there have been no reports regarding the correlation between inflammatory molecules and MMPs in fibroblasts of keratoconus. We further examined the mechanism of MMP-1 induction by inflammatory stimuli in a human corneal fibroblasts model in vitro. Our data show that either TNFa or IL-6 can up-regulate MMP-1 mRNA expression and protein synthesis in a dose-dependent manner and both TNF-a and IL-6 have a synergistic effect on the expression of MMP-1. A recent study has indicated that TNF-a and IL-6 may rank as important factors in the pathogenesis of keratoconus. 22 In addition, previous studies have showed that MMP-1, -2, -9 might be involved in the pathology of keratoconus; The thinning and ectasia of a keratoconus cornea have been mainly attributed to the increased degradation of ECM. 20, 22, 27, 28 Our study indicates that the overexpression of TNF-a and IL-6 in fibroblasts of keratoconus may be reflective of a chronic inflammatory situation by inducing MMP-1 expression, leading to degradation of corneal ECM.
It has been proposed that TNF-a is capable of inducing the expression of IL-6 in human corneal epithelial cells. 13,14 Our results show that TNF-a can enhance the IL-6 mRNA expression and protein synthesis in cultured fibroblasts of normal cornea and keratoconus in vitro. In addition, our experiments dada demonstrate that MMP-1 mRNA and protein expression induced by TNF-a significantly are inhibited after treatment with IL6 Ab and the inhibitory effect on MMP-1 protein in keratoconus was more significant than normal cornea.
The coculture of nerve cells with corneal fibroblasts increased the MMP-1 mRNA expression and protein synthesis with no effect on MMP-2 and MMP-9 expression in human corneal fibroblasts and furthermore, only the cytokine IL-6 in cocultures of the two cell types was significantly higher than that in cultures of corneal fibroblasts alone. These suggest that inflammatory cytokines and MMPs may play an important role in corneal inflammation, wound healing, and ECM degradation. 29 A report that showed lipopolysaccharide (LPS) stimulated MMP-1 and IL-6 secretion from macrophages and also found that LPS and IL-6 had a synergistic effect on MMP-1 expression, suggesting that IL-6 enhanced production of LPS-induced MMP-1. 30 Previous work suggested that heat shock can increase MMP-1, -3, and IL-6 at both the mRNA and protein levels and the expression of MMP-1,-3 increased by heat shock significantly was blocked after treatment with a monoclonal antibody against IL-6, indicating that IL-6 mediates the heat shock-induced MMP-1, -3 expression. 31 Similarly, in our experiment, IL-6 Ab was added to examine the effect of IL-6 Ab treatment on TNF-a-induced MMP-1 expression in fibroblasts of keratoconus and found that MMP-1 expression could be significantly inhibited in fibroblasts of keratoconus.
Put together, our study demonstrates that TNF-a up-regulated MMP-1 expression via IL-6 in fibroblasts of keratoconus. A recent research has found that subsequent treatment of keratoconus patients with cyclosporine A (CyA) reduced tear MMP-9 levels significantly and led to local reduction in corneal curvatures, indicating that CyA might be a novel treatment strategy in keratoconus. 32 It is worth mentioning that several IL-6 blocking agents such as a humanized anti-IL-6 receptor antibody has been developed and successfully applied in clinical trials for the treatment of several diseases. [33] [34] [35] MMP-1 reduction by IL-6 Ab might provide a new modality to reduce elevated MMP-1 levels in keratoconus.
Further studies are required to determine which signaling pathway being involved in the process: TNF-a ! IL-6 ! MMP-1 in keratoconus. It is possible that inhibiting IL-6 may help to dampen inflammatory responses mediated by TNF-a thereby reducing damage to the cornea. This may be realized by inhibiting IL-6 receptors or inhibition of targets downstream of the IL-6 signaling pathway or other pathways targeting IL-6 for treating keratoconus.
In conclusion, our findings indicate that fibroblasts of keratoconus show increased levels of IL-6 and MMP-1 gene and protein expression; IL-6 mediates the TNFa-induced MMP-1 expression in keratoconus.
